Blog Entry List
Oct 1, 2021 Update: The policy is amended with the effective date of Sept. 1, 2021.
Effective Aug. 18, 2021, the Medicaid and NC Health Choice programs cover anifrolumab-fnia injection
Providers are encouraged to confirm which PA types are included in this long-term design.
Tobacco-related policy requirements go into effect on July 1, 2022.
Two Months Left to Submit Program Year 2021 Attestations; Security Risk Analysis
Will cover all U.S. FDA approved CAR T-Cell Therapies when administered per U.S. FDA approved guidelines
Temporary Suspension of Prior Authorization for Post-Acute Placements and Temporary Availability of the Hospital at Home Program
This replaces the bulletin, published on Aug. 4, 2021
Tips for providers to reduce the likelihood of future documentation errors
Billing codes for Medicaid beneficiaries
Casirivimab and Imdevimab have been given emergency use authorization for treatment of mild to moderate COVID-19 in some patients.
Providers rendering personal care services subject to EVV through the prepaid health plan payer type have until Oct. 1, 2021 to complete EVV credentialing and begin processing EVV claims.
Taxonomy codes must be included when submitting claims to prepaid health plans